Rhône Capital has entered into a definitive agreement to sell a controlling interest in Arizona Chemical to American Securities, a New York-based private equity firm. Terms of the agreement have not been disclosed. The transaction, subject to regulatory approvals and customary closing conditions, is expected to close in the fourth quarter of this year. Rhône, along with other currentinvestors and the management team, will retain 25% of the company’s ownershipand will continue to partici...